SCHEMBL10889201

SCHEMBL10889201

N=Cc1ccoc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11388283 1.00
SCHEMBL11388286 0.78
SCHEMBL5321711 0.77 HCAR2 (0.48)
SCHEMBL357255 0.72
SCHEMBL4198201 0.72
SCHEMBL14306027 0.72
SCHEMBL10889197 0.72
SCHEMBL467876 0.72
Furan-3-Carbaldehyde SCHEMBL133204 0.72
SCHEMBL3094073 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104768549-A Selective inhibitors of undifferentiated cells YISSUM RES DEV CO 2015-07-08 CN claimed
EP-2266958-B1 Antiviral agent SHIONOGI & CO (JP) 2017-03-15 EP disclosed
CN-104768549-A Selective inhibitors of undifferentiated cells YISSUM RES DEV CO 2015-07-08 CN disclosed
US-4616015-A HYPOTENSIVE AGENT, ANTULCER AGENT, ANTICOAGULANT FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-10-07 US disclosed
EP-0122627-A2 Triazine derivatives, processes for preparation thereof and pharmaceutical compositions comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-10-24 EP disclosed